Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04088383
Other study ID # Rev0
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 10, 2019
Est. completion date November 30, 2022

Study information

Verified date February 2023
Source Globus Medical Inc
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate clinical outcomes of patients with plantar fasciitis following treatment with Amnios™ RT. Patients will be randomized to either Amnios™ RT or a placebo control.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date November 30, 2022
Est. primary completion date November 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 79 Years
Eligibility Inclusion Criteria: - Confirmed diagnosis of unilateral plantar fasciitis for = 1 month (30 days) and = 18 months by the Investigator - VAS Foot Pain score of at least 45mm (out of 100mm scale) at randomization - Plantar fasciitis with conservative treatment for = 1 month (30 days), including any of the following modalities: - RICE - Stretching exercises - NSAIDs - Orthotics - Diagnostic radiograph within 6 months of enrollment showing view of calcaneus, without evidence of calcaneal fracture or structural abnormalities - BMI = 40 kg/m2 - Age = 18 years and < 80 years - Willing and able to comply with the follow-up requirements of the protocol - Signed an Informed Consent Form specific to this research and agreed to release of medical information Exclusion Criteria: - Prior surgery or trauma resulting in severe, permanent damage to the affected foot - Require bilateral plantar fasciitis treatment at time of enrollment (with exception of compensatory symptoms on the non-affected foot) - Prior use of any lower limb injection therapy, including corticosteroids or PRP in either foot within the last 3 months - Has Type I or Type II diabetes mellitus - Systemic disorders associated with enthesopathy (disorder of entheses, i.e. bone attachments) such as Gout, reactive arthritis, rheumatoid arthritis, etc. - The presence of diagnosed comorbidities that can be confused with or can exacerbate the condition (as assessed by radiograph) including: - Calcaneal stress fracture - Nerve entrapment syndrome (diagnosed as Baxter Nerve Syndrome) - Fat pad atrophy (relative to expectations for patient's age) - Acute traumatic rupture of the plantar fascia - Calcaneal tumor - Tarsal tunnel syndrome (diagnosed) - Significant bone deformity of the foot that may interfere with the study - Other malignant tumors in the foot or conditions that may affect study outcomes - Affected site exhibits clinical signs and symptoms of infection of the foot in question - Known allergy or known sensitivity to aminoglycosides - Non-ambulatory - History of more than 14 days of treatment with immuno-suppressants (including systemic corticosteroids) or cytotoxic chemotherapy within 30 days prior to enrollment, or who are anticipated to require such medications during the course of the study - Prior radiation at the site, with exception of diagnostic radiographs - Use of any investigational drug(s) or investigational therapeutic device(s) within 3 months preceding enrollment - Immune disorders including Systemic Lupus Erythematosus (SLE), Fibromyalgia, Acquired Immunodeficiency Syndrome (AIDS) or Human Immunodeficiency Virus (HIV) - History of any condition (including drug or alcohol abuse, medical or psychiatric condition) that is likely to impair understanding of or compliance with the study protocol, in the judgment of the Investigator - Pregnancy at enrollment or within last 6 months, women who are breastfeeding, or women of childbearing potential who are planning to become pregnant during the time of the study OR are unwilling/unable to use acceptable methods of contraception (birth control pills, barriers, or abstinence) - Prisoner

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Amnios™ RT
Acellular human allograft
Saline
Sterile saline

Locations

Country Name City State
United States Bio-X-Cell Research San Antonio Texas

Sponsors (1)

Lead Sponsor Collaborator
Globus Medical Inc

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analog Scale (VAS) Foot Pain Score The visual analog scale (VAS) is a patient questionnaire used to quantify a subjective experience, such as the intensity of pain. The scale is a 100mm line labeled with "no pain" on the left border and "most intense pain imaginable" on the right border. The subject is instructed to place a vertical line on the scale that indicates the pain severity experienced; 0mm is equal to no pain and 100mm is most intense pain imaginable. Study staff records the distance of the patient's mark on the scale in millimeters. 3 Months
Primary Serious Adverse Events The occurrence of serious adverse events that are related to the product. 12 Months
See also
  Status Clinical Trial Phase
Completed NCT02546115 - RCT - Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis N/A
Terminated NCT01996111 - Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis N/A
Unknown status NCT01882894 - Efficacy of a Custom Temporary Foot Orthosis for Plantar Fasciitis Treatment N/A
Completed NCT01659827 - Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis N/A
Completed NCT00888394 - Effectiveness of Podiatry on Plantar Pain Phase 4
Completed NCT00758641 - Platelet Rich Plasma to Treat Plantar Fasciitis Phase 4
Terminated NCT00527748 - Foot and Ankle Range of Motion (Stretching) Apparatus N/A
Recruiting NCT05584046 - A Single-blind RCT to Investigate the Effect of a Novel Herbal Patch for the Treatment of PF N/A
Completed NCT01994759 - Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof. Phase 4
Completed NCT02646579 - Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only N/A
Completed NCT05592808 - Comparison of Taping Techniques in Plantar Fasciitis N/A
Not yet recruiting NCT04125264 - Intense Therapeutic Ultrasound (ITU) to Treat Plantar Fasciitis N/A
Completed NCT02546089 - ABI v Dry Needling for Plantar Fasciitis N/A
Completed NCT00765843 - A Trial of Custom Foot Orthoses for the Treatment of Plantar Heel Pain N/A
Completed NCT00155324 - Change and Clinical Significance of Plantar Fascia Thickness After ESWT N/A
Completed NCT04941469 - Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot N/A
Completed NCT06055933 - Effect of Kinesio Taping and Extracorporeal Shock Wave Therapy on Plantar Fasciitis
Recruiting NCT02539082 - the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis Phase 4
Enrolling by invitation NCT01786057 - Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis Phase 2/Phase 3
Recruiting NCT03978234 - Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain Phase 2